Genistein inhibits hypoxia, ischemic-induced death, and apoptosis in PC12 cells

Environ Toxicol Pharmacol. 2017 Mar:50:227-233. doi: 10.1016/j.etap.2017.01.022. Epub 2017 Feb 1.

Abstract

A hypoxia/ischemia neuronal model was established in PC12 cells using oxygen-glucose deprivation (OGD). OGD-induced neuronal death, apoptosis, glutamate receptor subunit GluR2 expression, and potassium channel currents were evaluated in the present study to determine the effects of genistein in mediating the neuronal death and apoptosis induced by hypoxia and ischemia, as well as its underlying mechanism. OGD exposure reduced the cell viability, increased apoptosis, decreased the GluR2 expression, and decreased the voltage-activated potassium currents. Genistein partially reversed the effects induced by OGD. Therefore, genistein may prevent hypoxia/ischemic-induced neuronal apoptosis that is mediated by alterations in GluR2 expression and voltage-activated potassium currents.

Keywords: Apoptosis; Genistein; Hypoxia/ischemia; Neuroprotection; PC12 cells.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Death / drug effects
  • Cell Hypoxia / drug effects
  • Gene Expression Regulation / drug effects
  • Genistein / pharmacology*
  • Ischemia / drug therapy
  • Neuroprotective Agents / pharmacology*
  • PC12 Cells
  • Potassium Channels / drug effects
  • Rats
  • Receptors, AMPA / metabolism*

Substances

  • Neuroprotective Agents
  • Potassium Channels
  • Receptors, AMPA
  • Genistein
  • glutamate receptor ionotropic, AMPA 2